Medical devices and diagnostics are among the most rapidly growing sectors of the healthcare industry. New medical devices have the potential, among other things, to make certain procedures less invasive, shorten recovery times, and improve patient outcomes. Diagnostics are informing treatment decisions and helping bring to fruition the promise of personalized medicine.
Location: Altoona, PA
|INRange Systems, Inc., has developed a remote medication management technology called EMMA®: Electronic Medication Management Assistant. The system allows a physician or pharmacist to remotely manage prescriptions stored in a device placed in the patient’s residence. It is of particular benefit to patients on complex drug regimens or whose mental faculties have been compromised, for situations in which compliance must be assured (e.g., mental health patients, clinical trials), and for settings involving Schedule I narcotics.
Location: Middletown, PA
|While there is a growing array of treatment options for age-related macular degeneration (AMD), there is currently no practical, low-cost method for detecting AMD at the early stages. MacuLogix, Inc. is developing a simple, cost-effective diagnostic tool for the early detection of AMD. Called AdaptDX, the device is based on dark adaptation, the transition from being light-adapted to being dark-adapted.|
CEO and Chairman
Location: Newtown, PA
|Micro Interventional Devices, Inc. (MID) is an early stage cardiovascular medical device company founded in May of 2010. MID is developing solutions to unmet needs in structural heart repair procedures, including transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement, LVAD placement, mitral valve repair, valvuloplasty, aortic arch repair, ASD and VSD closure, left atrial appendage closure, ablation of arrhythmia and other emerging structural heart repair procedures. MID is developing proprietary technology based on a breakthrough in soft-tissue anchoring and associated delivery devices that enable off-pump procedures.|
Location: Lehigh Valley
|Saladax Biomedical develops novel diagnostic assays for the practical delivery of personalized medicine and companion diagnostics. The company’s proprietary diagnostic tests improve the efficacy of cancer treatment by enabling oncologists to achieve optimal balance of efficacy and toxicity when administering chemotherapy agents. In addition, Saladax is a valuable partner for pharmaceutical and biotechnology companies in the development of companion diagnostics (CDx), addressing numerous risks and challenges in the new drug development process.|